The Allen Institute in Seattle says scientists have now learned enough about how the brain works to start fixing it when it breaks.
Allen Institute scientist Aaron Garcia (right) and executive vice president Ed Lein (left) examine a section of human brain in the lab. The institute has launched the Brain Health accelerator, which will focus on using genetic therapy to develop treatments for a range of brain disorders.
Erik Dinnel/Allen Institute
hide caption
toggle caption
Erik Dinnel/Allen Institute
Allen Institute launches $200M effort to turn brain atlas lessons into medicines
Brain mapping effort searches for roots of Parkinson’s and other diseases
AI-Powered drug discovery could transform treatment development for Alzheimer’s, Parkinson’s and other brain disorders.
AI’s next pharma challenge: tackling costly and risky clinical trials
Molecule glue drugs shake up cancer care, draw big money
Deep Science Ventures and Medicines Discovery Catapult partner to tackle brain drug delivery
Sean Parker’s $250 million cancer bet that rewrote the rules of medical collaboration
The Allen Institute is launching a $200 million initiative to explore specific neurodegenerative diseases and even develop drugs…
Allen Institute initiative aims to capture earliest cellular changes and identify new drug targets
The Biological Computing Co. (TBC) has raised $25 million in seed funding, Fortune has learned.
Gene therapy aims to target illness at its genetic source rather than manage symptoms. Here’s how the science works, and why…
Life Biosciences will test its gene therapy designed to partially reset a cell’s age and reverse vision loss in patients with…
NeuroXT and BIDMC Expand Collaboration to Advance AI-Driven Precision Treatment in Alzheimer's Disease
